Clavicular’s Girlfriend Retatrutide Protocol: Full Peptide Stack Breakdown
Retatrutide • Melanotan II • Looksmaxxing Research Stack
Clavicular’s Girlfriend Retatrutide Protocol: Full Peptide Stack Breakdown
Everything publicly known about the Clavicular girlfriend peptide protocol β compound by compound. Retatrutide mechanism, Melanotan II explained, and where to source each compound with Janoshik-verified COA documentation.
Research Use Disclaimer: All QSC products are sold strictly for in vitro laboratory research purposes only. They are not approved for human consumption, veterinary use, or any other application. Researchers are responsible for compliance with local regulations in their jurisdiction.
The Clavicular Girlfriend Peptide Stack β What Is Publicly Known
Clavicular is a prominent figure in the looksmaxxing and body optimisation research community, known for publicly referencing peptide protocols on social media. His girlfriend’s protocol has attracted significant attention, with searches for “clavicular girlfriend retatrutide” and “clavicular girlfriend peptide stack” generating substantial research interest.
Based on publicly shared content, the protocol centres on two primary compounds:
Primary Compound
Retatrutide
Triple GIP/GLP-1/Glucagon Agonist
Body composition, metabolic research, superior weight reduction vs mono and dual agonists in Phase 2 trials.
Retatrutide (LY3437943, developed by Eli Lilly) is a triple receptor agonist β the key distinction from better-known metabolic peptides is the number of receptor pathways it activates simultaneously:
Compound
Receptors Targeted
Mechanism
Phase 2 Weight Reduction
Semaglutide
GLP-1R
GLP-1 monoagonist
~15% (STEP 1)
Tirzepatide
GIP-R + GLP-1R
Dual GIP/GLP-1 agonist
~21% (SURMOUNT-1)
Retatrutide β
GIP-R + GLP-1R + Glucagon-R
Triple agonist
~24% (Phase 2 data)
The addition of glucagon receptor agonism is what separates Retatrutide from Tirzepatide. Glucagon receptor activation increases energy expenditure and hepatic glucose output β adding a thermogenic component to the appetite and insulin-sensitising effects of GLP-1R and GIP-R agonism.
QSC supplies Retatrutide in multiple configurations:
Melanotan II (MT-II) is a synthetic cyclic heptapeptide analogue of alpha-melanocyte stimulating hormone (Ξ±-MSH). It acts as a non-selective agonist at melanocortin receptors, with primary activity at:
MC1R
Melanocyte-stimulating receptor. Primary driver of melanogenesis β increases eumelanin production, resulting in skin darkening.
MC3R
Expressed in hypothalamus and limbic system. Involved in energy homeostasis and metabolic regulation research.
MC4R
Hypothalamic receptor. Central to appetite suppression and autonomic function research. Also mediates erectile function signalling.
In the looksmaxxing research context, Melanotan II is studied for its melanogenesis effects (tanning without UV exposure) and appetite modulation via MC4R. It complements Retatrutide’s body composition mechanism through a distinct, non-overlapping pathway.
The Full Clavicular Stack at QSC
Beyond the girlfriend protocol, Clavicular’s full publicly referenced stack is a 7-compound looksmaxxing and body optimisation blend. QSC supplies this as a pre-assembled kit:
Featured Stack
QSC Clavicular Looksmaxxing Stack
7 compounds Γ 10 vials each = 70 vials total. All compounds verified at β₯99% purity with Janoshik COA. Domestic shipping from USA, EU, UK, Canada, and Australia.
7 Compounds 70 Vials Total β₯99% Purity Janoshik COA Included
Where to Source the Clavicular Girlfriend Protocol Compounds
Both Retatrutide and Melanotan II are available individually at QSC with full Janoshik COA verification. Domestic shipping from five regional warehouses means no customs delays for researchers in the USA, EU, UK, Canada, or Australia.
Clavicular’s publicly referenced peptide stack includes Retatrutide (triple GIP/GLP-1/glucagon agonist), Melanotan II (melanocortin receptor agonist), and additional compounds targeting bone density, growth hormone secretion, and body composition. QSC supplies all compounds individually and as the pre-assembled Clavicular Stack kit.
What is the Clavicular girlfriend retatrutide protocol?
Based on publicly shared content, the protocol centres on Retatrutide as a triple GIP/GLP-1/glucagon agonist for body composition research, combined with Melanotan II for melanocortin-pathway research. Retatrutide acts on three receptor pathways simultaneously β distinct from GLP-1 monoagonists (Semaglutide) or dual agonists (Tirzepatide).
Where can I buy the Clavicular peptide stack?
QSC supplies the complete Clavicular Stack as a pre-assembled 7-compound kit (70 vials total) plus all individual compounds separately. All are verified at β₯99% purity with Janoshik COA documentation. Domestic shipping from USA, EU, UK, Canada, and Australia.
What is Retatrutide and how does it work?
Retatrutide (LY3437943) is a triple receptor agonist targeting GIP-R, GLP-1R, and glucagon-R simultaneously. Phase 2 data showed greater body weight reduction (~24%) than Semaglutide (~15%) or Tirzepatide (~21%). The glucagon receptor component adds energy expenditure effects not seen in dual or mono agonists.
What is Melanotan II?
Melanotan II is a synthetic Ξ±-MSH analogue acting on melanocortin receptors (MC1R, MC3R, MC4R). Research applications include melanogenesis (tanning without UV), appetite suppression via MC4R, and autonomic function studies. QSC supplies it as a lyophilized research peptide with Janoshik COA documentation.
